Press Releases about Ensysce Biosciences Inc
Ensysce Biosciences Regains Compliance with Nasdaq
May 28, 2024
Via ACCESSWIRE
Ensysce Biosciences Receives Positive Nasdaq Listing Determination
February 27, 2024
Via ACCESSWIRE
Via ACCESSWIRE
Ensysce Biosciences Issues 2024 Shareholder Letter
January 08, 2024
Via ACCESSWIRE
Ensysce Biosciences Postpones Special Meeting of Stockholders to December 29, 2023
December 19, 2023
Via ACCESSWIRE
Ensysce Biosciences Announces Key Efficacy Data for Lead Analgesic
December 14, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Ensysce Biosciences Reports Third Quarter 2023 Financial Results
November 09, 2023
Via ACCESSWIRE
Ensysce Biosciences Secures $1.7 Million Convertible Note Financing
October 24, 2023
Via ACCESSWIRE
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.